BlackRock Fund Advisors - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 24 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$306,000
-8.9%
19,623
-23.8%
0.00%
Q3 2016$336,000
+189.7%
25,739
+52.5%
0.00%
Q2 2016$116,000
-86.4%
16,878
-81.3%
0.00%
Q1 2016$851,000
-11.3%
90,105
-5.4%
0.00%
Q4 2015$959,000
-18.7%
95,220
+15.4%
0.00%
Q3 2015$1,180,00082,4780.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Prentice Capital Management, LP 390,381$1,292,0000.49%
ETF MANAGERS GROUP, LLC 891,025$2,949,0000.09%
AdvisorShares Investments LLC 353,009$1,168,0000.06%
ALGERT GLOBAL LLC 51,028$169,0000.05%
Bernardo Wealth Planning LLC 27,219$90,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 31,552$104,0000.03%
ZEKE CAPITAL ADVISORS, LLC 49,700$165,0000.02%
Walleye Capital LLC 51,554$171,0000.02%
Dynamic Technology Lab Private Ltd 19,021$63,0000.01%
J.W. COLE ADVISORS, INC. 37,064$123,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders